ArticleThe journal of prevention of Alzheimer's disease2026
From regulatory approval to clinical practice: real-world eligibility for anti-amyloid monoclonal antibodies in an Italian dementia-care network.
Giovanna Zamboni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.